Compile Data Set for Download or QSAR
Report error Found 404 Enz. Inhib. hit(s) with all data for entry = 5943
TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102168(US8530648, 75)
Affinity DataKi:  1nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102172(US8530648, 94)
Affinity DataKi:  3nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102276(US8530648, 213)
Affinity DataKi:  7nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102168(US8530648, 75)
Affinity DataKd:  7nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102224(US8530648, 161)
Affinity DataKi:  8nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102258(US8530648, 195)
Affinity DataKi:  9nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102265(US8530648, 202)
Affinity DataKi:  11nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102293(US8530648, 230)
Affinity DataKd:  12nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102172(US8530648, 94)
Affinity DataKd:  12nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102306(US8530648, 243)
Affinity DataKi:  13nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102168(US8530648, 75)
Affinity DataKi:  13nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102293(US8530648, 230)
Affinity DataKi:  14nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102171(US8530648, 85)
Affinity DataKi:  16nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102168(US8530648, 75)
Affinity DataKd:  17nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102278(US8530648, 215)
Affinity DataKi:  19nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102172(US8530648, 94)
Affinity DataKi:  20nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102135(US8530648, 32)
Affinity DataKi:  22nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102285(US8530648, 222)
Affinity DataKi:  23nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102194(US8530648, 131)
Affinity DataKi:  23nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102264(US8530648, 201)
Affinity DataKi:  24.2nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102169(US8530648, 78)
Affinity DataKi:  25nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102258(US8530648, 195)
Affinity DataKd:  25nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102259(US8530648, 196)
Affinity DataKi:  29nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102132(US8530648, 29)
Affinity DataKi:  30nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102131(US8530648, 28)
Affinity DataKi:  30nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102303(US8530648, 240)
Affinity DataKi:  32nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102177(US8530648, 107)
Affinity DataKi:  32nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102306(US8530648, 243)
Affinity DataKd:  34nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102132(US8530648, 29)
Affinity DataKd:  34nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102143(US8530648, 40)
Affinity DataKi:  35nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102139(US8530648, 36)
Affinity DataKi:  35nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102224(US8530648, 161)
Affinity DataKd:  36nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102172(US8530648, 94)
Affinity DataKd:  36nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102171(US8530648, 85)
Affinity DataKd:  36nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102178(US8530648, 111)
Affinity DataKi:  39nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102272(US8530648, 209)
Affinity DataKi:  39nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102303(US8530648, 240)
Affinity DataKd:  41nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102131(US8530648, 28)
Affinity DataKd:  42nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102279(US8530648, 216)
Affinity DataKi:  45nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102134(US8530648, 31)
Affinity DataKi:  46nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102173(US8530648, 97)
Affinity DataKi:  47nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102183(US8530648, 120)
Affinity DataKi:  47nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102174(US8530648, 98)
Affinity DataKi:  48nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102189(US8530648, 126)
Affinity DataKi:  49nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102227(US8530648, 164)
Affinity DataKi:  50nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102272(US8530648, 209)
Affinity DataKd:  50nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102152(US8530648, 49)
Affinity DataKi:  51nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102202(US8530648, 139)
Affinity DataKi:  55nMpH: 7.4Assay Description:FLIPR assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Novartis

US Patent
LigandPNGBDBM102174(US8530648, 98)
Affinity DataKd:  56nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Novartis

US Patent
LigandPNGBDBM102152(US8530648, 49)
Affinity DataKd:  59nMpH: 7.5Assay Description:Radioligand binding assay using orexin receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2013
Entry Details
US Patent

Displayed 1 to 50 (of 404 total ) | Next | Last >>
Jump to: